EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Variation Analysis in Premenopausal and Postmenopausal Breast Cancer Cases

Ibrahim Halil Erdogdu, Seda Orenay-Boyacioglu iD, Olcay Boyacioglu iD, Duygu Gurel, Nurten Akdeniz, Ibrahim Meteoglu

Journal of Personalized Medicine · 20.04.2024 · 14 (4) · 434

DOI: 10.3390/jpm14040434 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 20.04.2024. Verfasst von Ibrahim Halil Erdogdu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathology, Faculty of Medicine, Aydin Adnan Menderes University, 09010 Aydin, Turkey. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Menopausal status affects the prognoses and consequences of breast cancer. Therefore, this retrospective study aimed to reveal the molecular variation profile differences in breast cancer patients according to their menopausal status, with the hypothesis that the molecular variation profiles will be different at premenopausal and postmenopausal ages. Breast cancer patients (n = 254) who underwent molecular subtyping and QIAseq Human Breast Cancer NGS Panel screening between 2018 and 2022 were evaluated retrospectively. Their menopausal status was defined by age, and those aged 50 years and above were considered postmenopausal. Of the subjects, 58.66% (n = 149) were premenopausal and 41.34% (n = 105) were postmenopausal. The mean age at the time of diagnosis for all patients was 49.31 ± 11.19 years, with respective values of 42.11 ± 5.51 and 59.54 ± 9.01 years for the premenopausal and postmenopausal groups, respectively (p = 0.000). Among premenopausal patients, the percentages of patients in BCa subtypes (luminal A, luminal B-HER2(−), luminal B-HER2(+), HER2 positive, and triple-negative) were determined to be 34.90%, 8.05%, 26.17%, 10.74%, and 20.13%, respectively, while in the postmenopausal group, these values were 39.05%, 16.19%, 24.76%, 6.67%, and 13.33%, respectively (p > 0.05). Considering menopausal status, the distribution of hormone receptors in premenopausal patients was ER(+)/PgR(+) 63.76%, ER(−)/PgR(−) 23.49%, ER(+)/PgR(−) 10.74%, and ER(−)/PgR(+) 2.01%, respectively, while in postmenopausal women, this distribution was observed to be 74.29%, 23.81%, 1.90% and 0.00% in the same order (p = 0.008). The most frequently mutated gene was TP53 in 130 patients (51.18%), followed by PIK3CA in 85 patients (33.46%), BRCA2 and NF1 in 56 patients (22.05%), PTEN in 54 patients (21.26%), and ATR and CHEK2 in 53 patients (20.87%). TP53, PIK3CA, NF1, BRCA2, PTEN, and CHEK2 mutations were more frequently observed in premenopausal patients, while TP53, PIK3CA, BRCA2, BRCA1, and ATR mutations in postmenopausal patients. These findings contribute to a deeper understanding of the underlying causes of breast cancer with respect to menopausal status. This study is the first from Turkey that reflects the molecular subtyping and somatic mutation profiles of breast cancer patients according to menopausal status.

Schlagwörter

Stichwörter der Autor:innen

NGSbreast cancergene variationsmolecular subtyping

Autor:innen und Institutionen

  • Department of Molecular Pathology, Faculty of Medicine, Aydin Adnan Menderes University, 09010 Aydin, Turkey.
  • Department of Medical Genetics, Faculty of Medicine, Aydin Adnan Menderes University, 09010 Aydin, Turkey.
  • Faculty of Engineering, Aydin Adnan Menderes University, 09010 Aydin, Turkey.
  • Department of Pathology, Faculty of Medicine, Dokuz Eylul University, 35220 Izmir, Turkey.
  • Private Obstetrics & Gynecology, and Infertility Clinic, 35050 Izmir, Turkey.

ORCID-Profile: Seda Orenay-Boyacioglu, Olcay Boyacioglu

Zitieren

APA

Erdogdu, I. H., Orenay-Boyacioglu, S., Boyacioglu, O., Gurel, D., Akdeniz, N., & Meteoglu, I. (2024). Variation Analysis in Premenopausal and Postmenopausal Breast Cancer Cases. Journal of Personalized Medicine, 14(4), 434. https://doi.org/10.3390/jpm14040434

Vancouver

Erdogdu IH, Orenay-Boyacioglu S, Boyacioglu O, Gurel D, Akdeniz N, Meteoglu I. Variation Analysis in Premenopausal and Postmenopausal Breast Cancer Cases. Journal of Personalized Medicine. 2024;14(4):434. doi:10.3390/jpm14040434

BibTeX
@article{Erdogdu2024,
  author = {Erdogdu, Ibrahim Halil and Orenay-Boyacioglu, Seda and Boyacioglu, Olcay and Gurel, Duygu and Akdeniz, Nurten and Meteoglu, Ibrahim},
  title = {Variation Analysis in Premenopausal and Postmenopausal Breast Cancer Cases},
  journal = {Journal of Personalized Medicine},
  year = {2024},
  volume = {14},
  number = {4},
  pages = {434},
  doi = {10.3390/jpm14040434}
}
Kostenlos starten →